ULTRAGENYX PHARMACEUTICAL INC. 5,072,464 Shares of Common Stock Underwriting AgreementUltragenyx Pharmaceutical Inc. • March 1st, 2019 • Pharmaceutical preparations • New York
Company FiledMarch 1st, 2019 Industry JurisdictionUltragenyx Pharmaceutical Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”) an aggregate of 5,072,464 shares (the “Underwritten Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 760,869 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.”